Come up with a name for your new list and we'll add to it:
Promethera Biosciences raised a round of funding on , . Investors include
Universite Catholique de Louvain.
Promethera Biosciences is a pharmaceutical company that develops therapies for the treatment of liver disease. It is developing products based on a newly discovered and patented cell, the Heterologous…